PCI further expands into New England with fill-finish upgrade in New Hampshire
A Philadelphia-based CDMO will drop $100 million into its aseptic liquid fill-finish and sterile lyophilization technology at its recently-acquired Bedford, NH campus.
PCI Pharma bought the Lyophilization Services of that New England site at the end of 2021. The new expansion will add a 50,000 square-foot facility that features a fill-finish line with a fully isolated containment system. It will have the capacity to fill 400 vials per minute, which will help PCI up its speed and get therapies to patients quicker.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.